New Mexico 2023 Regular Session

New Mexico Senate Bill SB132

Introduced
1/19/23  
Report Pass
2/6/23  
Report Pass
2/22/23  
Engrossed
2/27/23  
Report Pass
3/8/23  
Report Pass
3/10/23  
Enrolled
3/16/23  
Chaptered
4/4/23  

Caption

Sti Prevention & Treatment

Impact

The ramifications of SB132 are expected to enhance healthcare accessibility for individuals at risk of STIs. By removing cost-sharing, it is anticipated that more people will seek preventive care and treatment, leading to early detection and management of infections. The bill explicitly states that age and gender identity cannot restrict access to these health services, promoting inclusivity within the healthcare system. The provisions apply to various health insurance plans that are renewed or issued in New Mexico after January 1, 2024, making it a substantial shift in existing laws governing health insurance coverage.

Summary

SB132, a legislative proposal primarily focused on health care, aims to eliminate cost-sharing requirements for preventive care and treatment related to sexually transmitted infections (STIs). If enacted, the bill would ensure that group health coverage and health insurance policies must cover preventive care and treatments for STIs without imposing any cost-sharing requirements such as deductibles or copayments. This change is significant as it emphasizes accessibility and preventive healthcare measures in managing STIs, which affect a broad segment of the population.

Sentiment

The overall sentiment around SB132 is largely positive, particularly among public health advocates and healthcare providers who view the elimination of cost-sharing as a necessary step toward improving public health outcomes. However, some opposition exists, focusing on concerns about potential financial impacts on health insurance providers and whether such mandates may lead to higher premiums overall. Despite this contention, proponents argue that the long-term benefits to public health and potential cost savings from reduced STI complications far outweigh these concerns.

Contention

Notable points of contention related to SB132 arise from debates on the implications for insurance companies and the potential for increased healthcare costs. Critics of the bill suggest that the elimination of cost-sharing requirements could burden health insurers, who may subsequently raise premiums to compensate for the lack of cost-recovery on preventive services. Furthermore, discussions have highlighted the delicate balance between ensuring equitable access to healthcare and maintaining the financial sustainability of health insurance systems. These discussions underscore the importance of carefully considering the broader impacts of health legislation.

Companion Bills

No companion bills found.

Previously Filed As

NM SB166

Sti Prevention & Treatment

NM SB048

Diabetes Prevention & Obesity Treatment Act

NM SB120

No Behavioral Health Cost Sharing

NM SB054

Diabetes Prevention & Obesity Treatment Act

NM AB350

Health care coverage: fluoride treatments.

NM SB51

Cost-sharing Contributions For Prescriptions

NM SB443

No Cholesterol-lowering Drug Cost Sharing

NM S0563

Insurance Coverage For Prevention Of Hiv Infection

NM HB1966

Relating To Health Care.

NM SB2605

Relating To Health Care.

Similar Bills

NM SB166

Sti Prevention & Treatment

CA AB2204

Health care coverage: sexually transmitted diseases.

CA AB1683

Sexually transmitted diseases: prevention and control.

AZ SB1085

Time limitation; DUI prosecutions

AZ HB2728

DUI; alternative treatment

AZ SB1025

DUI threshold; drivers

CA AB598

San Francisco Bay Area Regional Housing Finance Act: regional and county expenditure plans.

CA AB643

Pupil instruction: abusive relationships.